Emerging Copper-Based Developments in PSMA Imaging

Author(s):

Michael Gorin, MD

A medical expert discusses how emerging copper-based developments in PSMA imaging, particularly the 64Cu-SAR-bisPSMA agent, offer advancements in tumor detection and imaging logistics compared to traditional agents.

Video Player is loading.

Current Time

Duration

Loaded: 0%

Stream Type LIVE

Remaining Time

EP: 1.PSMA PET Imaging: The Landscape and Current Challenges

Now Viewing

EP: 2.Emerging Copper-Based Developments in PSMA Imaging

EP: 3.COBRA AND PROPELLER: Background and Results of Prior PSMA Imaging Trials

EP: 4.The CLARIFY Trial Design and Objectives for PSMA Imaging

EP: 5.Potential Impact of Forthcoming CLARIFY Trial Results

Recent Content

Human kidney stones | Image Credit: © freshidea - stock.adobe.com

Study results show CVAC 2.0 is safe, efficacious for wide range of kidney stones

FDA Advisory Committee unanimously votes against talazoparib plus enzalutamide for mCRPC

FDA Advisory Committee finds evidence for UGN-102 inconclusive, cites uncertainty in benefit-risk

Pivotal trial launches of 64Cu-SAR-bisPSMA in BCR of prostate cancer

View More Recent Content

Do not sell my Personnal Information

Contact Info

2 Commerce Drive
Cranbury, NJ 08512

609-716-7777